Health · Public Health & Disease · 17 hrs ago
Mexico contracts for up to 2.5 million COVID-19 vaccines through 2030
Mexico’s state-run Birmex has awarded a contract to private company Laboratorios Liomont for up to 2.5 million COVID-19 vaccines.
The contract sets a minimum value of $700 million and a maximum of $1.75 billion before taxes.
Deliveries began on September 13 and are scheduled to continue through December 31, 2030.
The deal comes after Mexico’s planned Patria vaccine failed to move into production, despite earlier promises that it would be available.
Birmex says seasonal vaccination can help reduce hospital stays and deaths, especially among vulnerable people.
The vaccines must be kept within specified temperature limits during storage and transport, or Birmex can reject them.
The contract does not say how many doses will be delivered in each year.
Mexico’s state-owned Birmex awarded Laboratorios Liomont a contract to supply up to 2.5 million COVID-19 vaccines.
The contract has a minimum value of $700 million and a maximum of $1.75 billion before taxes.
Deliveries began on September 13 and are scheduled to continue through December 31, 2030.
Birmex said the vaccines are intended to support seasonal vaccination and must be transported under monitored temperature conditions.
The report says Mexico’s Patria vaccine has not begun production.
- Who
- Birmex awarded the contract to Laboratorios Liomont.
- What
- The contract covers up to 2.5 million COVID-19 vaccines, with a minimum value of $700 million and a maximum of $1.75 billion before taxes.
- When
- Deliveries began September 13 and are scheduled to run through December 31, 2030.
- Where
- Mexico.
- Why
- Birmex said seasonal COVID-19 vaccination can reduce hospitalizations and deaths, particularly among vulnerable groups.
This story does not have two clearly opposing sides.
Laboratorios Liomont is hereby informed that it is awarded the direct contract for the acquisition of the SARS-CoV-2 vaccine. The minimum amount is $700,000,000, and the maximum amount is $1,750,000,000 dollars before taxes.
These conditions allow the creation of national strategic reserves that can be released in stages according to the needs of the health system.
Then-President Andrés Manuel López Obrador promised that Mexico would have its own COVID-19 vaccine and that it would be administered in November that year.
Birmex’s Administration and Finance Directorate directly awarded the contract to Laboratorios Liomont.
The contract’s delivery period began.
The contract’s delivery period is scheduled to end.
- Maximum quantity
- 2.5 million COVID-19 vaccines
- Contract minimum
- $700 million before taxes
- Contract maximum
- $1.75 billion before taxes
- Supplier
- Laboratorios Liomont
- Contracting agency
- Birmex
Sources
Related news
Chickenpox was the most common infection in South Korea’s military from 2022 to 2026
Community-led initiative to address drug abuse launched in 300 Jind villages
WHO says cause of Russian lab worker’s death remains unknown
Russia ends checks after Siberian lab worker’s death, but cause remains unknown
About 1,300 to 1,400 people seek care after illness in Tokat
Brazil approves first human tests of vaccine against a major malaria parasite
Drug-resistant Shigella is becoming more common in the U.S
Kenya’s First Ebola Patient Travelled Through DR Congo and Uganda Undetected
Kenyan patient suspected of Ebola tests negative in preliminary results
Astra and Indonesian government expand village stunting prevention program
Pasteur chief urges calm amid plague suspicions in Russia
